Preterm Prelabor Rupture of Membranes and Severe Oligohydramnios from 22-34 Weeks of Amenorrhea
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Preterm Premature Rupture of Membranes
Perinatal Manual of Southwestern Ontario Southwestern Ontario Maternal, Newborn, Child & Youth Network (MNCYN) Perinatal Outreach Program Chapter 10 PRETERM PRE-LABOUR RUPTURE OF MEMBRANES (PPROM) When there is a spontaneous rupture of membranes in a pregnancy less than 37 weeks gestation. Incidence - occurs in 2 to 3.5 % of all pregnancies but accounts for 1/3 of all cases of preterm delivery. Diagnosis Diagnosis of PPROM is made by a combination of patient history, clinical suspicion, physical exam, and some testing. Patient history has an accuracy of 90% for the diagnosis of PPROM and should not be ignored. 1. Sterile speculum examination for visualization of amniotic fluid cascade, or pooling of fluid in posterior vaginal fornix. (Ultrasound may be used as an adjunct in the diagnosis; however, amniotic fluid volume alone is not specific for PPROM.) 2. Visual assessment of cervical dilation. Routine digital cervical exam is not recommended unless the patient is in labour. Laboratory / Diagnostic Evaluation 1. Assess for chorioamnionitis: maternal fever, CBC and differential, fetal tachycardia, uterine tenderness 2. Assess for fetal well-being: nonstress test to establish heart rate baseline, reactivity, and presence or absence of accelerations or decelerations. 3. Assess for presence of contractions. 4. Take swab for Group B Strep from lower 1/3 of the vagina and anus using the same swab as per usual GBS culture methodology. 5. Ultrasound: Performed to establish fetal position, establish/confirm fetal growth, anatomy, and fluid volume. Biophysical profile is performed as clinically indicated, recognizing that 2 points may be lost for lack of fluid volume. If ultrasound is not available and fetal position is not certain based on Leopold’s Manoeuvres, a vaginal REVISED OCTOBER 2018 10-1 Disclaimer The Southwestern Ontario Maternal, Newborn, Child & Youth Network (MNCYN) has used practical experience and relevant legislation to develop this manual chapter. -
Prolonged Preterm Rupture of Fetal Membranes, a Consequence of an Increased Maternal Anti-Fetal T Cell Responsiveness
0031-3998/05/5804-0648 PEDIATRIC RESEARCH Vol. 58, No. 4, 2005 Copyright © 2005 International Pediatric Research Foundation, Inc. Printed in U.S.A. Prolonged Preterm Rupture of Fetal Membranes, a Consequence of an Increased Maternal Anti-fetal T Cell Responsiveness ANDREA STEINBORN, EDGAR SCHMITT, YVONNE STEIN, ANDREAS KLEE, MARKUS GONSER, ERHARD SEIFRIED, AND CHRISTIAN SEIDL Department of Obstetrics and Gynecology [A.S., Y.S.], University of Frankfurt, 60590 Frankfurt/Main, Germany; Institute of Immunology [E.Sc.], University of Mainz, 55131 Mainz, Germany; Department of Obstetrics and Gynecology [A.K., M.G.], Dr. Horst-Schmidt Hospital, 65199 Wiesbaden, Germany; and Institute of Transfusion Medicine and Immunohaematology [E.Se., C.S.], Blood Transfusion Center of the German Red Cross, 60528 Frankfurt, Germany ABSTRACT A fetus, although semi-allogeneic, is usually accepted by the with women with uncontrollable preterm labor. Our results re- maternal immune system. However, complications, including vealed a strongly reduced allogeneic T cell response of PBMCs alloresponsive mechanisms, are thought to be potentially detri- from pregnant women that was further down-regulated when mental for a successful pregnancy. Therefore, we compared PBMCs from their own fetus were used as stimulators. By allogeneic T cell responses of nonpregnant women with the contrast, data from women with PPROM suggest an increased response of healthy pregnant women and pregnant women who maternal T cell response specifically toward the fetal HLA have various gestation-associated diseases. Peripheral blood antigens.(Pediatr Res 58: 648–653, 2005) mononuclear cells (PBMCs) of all three groups were stimulated with PBMCs from unrelated volunteers. Pregnant women had Abbreviations significantly reduced stimulation indices (SIs) compared with CTG, cardiotocogram nonpregnant women. -
Management of Prolonged Decelerations ▲
OBG_1106_Dildy.finalREV 10/24/06 10:05 AM Page 30 OBGMANAGEMENT Gary A. Dildy III, MD OBSTETRIC EMERGENCIES Clinical Professor, Department of Obstetrics and Gynecology, Management of Louisiana State University Health Sciences Center New Orleans prolonged decelerations Director of Site Analysis HCA Perinatal Quality Assurance Some are benign, some are pathologic but reversible, Nashville, Tenn and others are the most feared complications in obstetrics Staff Perinatologist Maternal-Fetal Medicine St. Mark’s Hospital prolonged deceleration may signal ed prolonged decelerations is based on bed- Salt Lake City, Utah danger—or reflect a perfectly nor- side clinical judgment, which inevitably will A mal fetal response to maternal sometimes be imperfect given the unpre- pelvic examination.® BecauseDowden of the Healthwide dictability Media of these decelerations.” range of possibilities, this fetal heart rate pattern justifies close attention. For exam- “Fetal bradycardia” and “prolonged ple,Copyright repetitive Forprolonged personal decelerations use may onlydeceleration” are distinct entities indicate cord compression from oligohy- In general parlance, we often use the terms dramnios. Even more troubling, a pro- “fetal bradycardia” and “prolonged decel- longed deceleration may occur for the first eration” loosely. In practice, we must dif- IN THIS ARTICLE time during the evolution of a profound ferentiate these entities because underlying catastrophe, such as amniotic fluid pathophysiologic mechanisms and clinical 3 FHR patterns: embolism or uterine rupture during vagi- management may differ substantially. What would nal birth after cesarean delivery (VBAC). The problem: Since the introduction In some circumstances, a prolonged decel- of electronic fetal monitoring (EFM) in you do? eration may be the terminus of a progres- the 1960s, numerous descriptions of FHR ❙ Complete heart sion of nonreassuring fetal heart rate patterns have been published, each slight- block (FHR) changes, and becomes the immedi- ly different from the others. -
00005721-201907000-00003.Pdf
2.0 ANCC Contact Hours Angela Y. Stanley, DNP, APRN-BC, PHCNS-BC, NEA-BC, RNC-OB, C-EFM, Catherine O. Durham, DNP, FNP-BC, James J. Sterrett, PharmD, BCPS, CDE, and Jerrol B. Wallace, DNP, MSN, CRNA SAFETY OF Over-the-Counter MEDICATIONS IN PREGNANCY Abstract Approximately 90% of pregnant women use medications while they are pregnant including both over-the-counter (OTC) and prescription medications. Some medica- tions can pose a threat to the pregnant woman and fetus with 10% of all birth defects directly linked to medications taken during pregnancy. Many medications have docu- mented safety for use during pregnancy, but research is limited due to ethical concerns of exposing the fetus to potential risks. Much of the information gleaned about safety in pregnancy is collected from registries, case studies and reports, animal studies, and outcomes management of pregnant women. Common OTC categories of readily accessible medications include antipyretics, analgesics, nonsteroidal anti- infl ammatory drugs, nasal topicals, antihistamines, decongestants, expectorants, antacids, antidiar- rheal, and topical dermatological medications. We review the safety categories for medications related to pregnancy and provide an overview of OTC medications a pregnant woman may consider for management of common conditions. Key words: Pharmacology; Pregnancy; Safety; Self-medication. Shutterstock 196 volume 44 | number 4 July/August 2019 Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved. he increased prevalence of pregnant women identifi ed risks in animal-reproduction studies or completed taking medications, including over-the-counter animal studies show no harm. The assignment of Category (OTC) medications presents a challenge to C has two indications; (1) limited or no research has been nurses providing care to women of childbear- conducted about use in pregnancy, and (2) animal studies ing age. -
Dermatology and Pregnancy* Dermatologia E Gestação*
RevistaN2V80.qxd 06.05.05 11:56 Page 179 179 Artigo de Revisão Dermatologia e gestação* Dermatology and pregnancy* Gilvan Ferreira Alves1 Lucas Souza Carmo Nogueira2 Tatiana Cristina Nogueira Varella3 Resumo: Neste estudo conduz-se uma revisão bibliográfica da literatura sobre dermatologia e gravidez abrangendo o período de 1962 a 2003. O banco de dados do Medline foi consul- tado com referência ao mesmo período. Não se incluiu a colestase intra-hepática da gravidez por não ser ela uma dermatose primária; contudo deve ser feito o diagnóstico diferencial entre suas manifestações na pele e as dermatoses específicas da gravidez. Este apanhado engloba as características clínicas e o prognóstico das alterações fisiológicas da pele durante a gravidez, as dermatoses influenciadas pela gravidez e as dermatoses específi- cas da gravidez. Ao final apresenta-se uma discussão sobre drogas e gravidez Palavras-chave: Dermatologia; Gravidez; Patologia. Abstract: This study is a literature review on dermatology and pregnancy from 1962 to 2003, based on Medline database search. Intrahepatic cholestasis of pregnancy was not included because it is not a primary dermatosis; however, its secondary skin lesions must be differentiated from specific dermatoses of pregnancy. This overview comprises clinical features and prognosis of the physiologic skin changes that occur during pregnancy; dermatoses influenced by pregnancy and the specific dermatoses of pregnancy. A discussion on drugs and pregnancy is presented at the end of this review. Keywords: Dermatology; Pregnancy; Pathology. GRAVIDEZ E PELE INTRODUÇÃO A gravidez representa um período de intensas ções do apetite, náuseas e vômitos, refluxo gastroeso- modificações para a mulher. Praticamente todos os fágico, constipação; e alterações imunológicas varia- sistemas do organismo são afetados, entre eles a pele. -
Concurrence of Decreases in Barometric Pressure and Spontaneous Rupture of Membranes in Term Gravid Women Linda M
Grand Valley State University ScholarWorks@GVSU Masters Theses Graduate Research and Creative Practice 1999 Concurrence of Decreases in Barometric Pressure and Spontaneous Rupture of Membranes in Term Gravid Women Linda M. Owen Grand Valley State University Follow this and additional works at: http://scholarworks.gvsu.edu/theses Part of the Nursing Commons Recommended Citation Owen, Linda M., "Concurrence of Decreases in Barometric Pressure and Spontaneous Rupture of Membranes in Term Gravid Women" (1999). Masters Theses. 510. http://scholarworks.gvsu.edu/theses/510 This Thesis is brought to you for free and open access by the Graduate Research and Creative Practice at ScholarWorks@GVSU. It has been accepted for inclusion in Masters Theses by an authorized administrator of ScholarWorks@GVSU. For more information, please contact [email protected]. Concurrence of Decreases in Barometric Pressure and Spontaneous Rupture of Membranes in Term Gravid Women by Linda M. Owen A Thesis Grand Valley State University Kirkhof School of Nursing 1999 Thesis Committee Members: Patricia Underwood, Ph D. R.N. Lorraine Rodrigues-Fisher, Ed.D. R.N. Theresa Bacon-Baguley, Ph.D., R.N. ABSTRACT CONCURRENCE OF DECREASES IN BAROMETRIC PRESSURE AND SPONTANEOUS RUPTURE OF MEMBRANES IN TERM GRAVID WOMEN BY LINDA M. OWEN A retrospective design was used to examine the relationship between spontaneous rupture of membranes in term gestation gravid women and decreased barometric pressure of ten millibars or greater in the twenty-four hours proceeding the rupture of membranes. Delivery logbooks and charts of all women who were admitted to a Midwestern Hospital in 1997-1998 with spontaneous rupture of membranes (N-533) were examined and data from the Midwest Climate Center was utilized to determine the changes in barometric pressure within the twenty-four hours proceeding the documented rupture of membranes. -
Perinatal Outcomes Associated with Latency in Late Preterm Premature Rupture of Membranes
International Journal of Environmental Research and Public Health Article Perinatal Outcomes Associated with Latency in Late Preterm Premature Rupture of Membranes Eui Kyung Choi 1 , So Yeon Kim 2, Ji-Man Heo 2, Kyu Hee Park 1 , Ho Yeon Kim 2,*, Byung Min Choi 1 and Hai-Joong Kim 2 1 Department of Pediatrics, Division of Neonatology, Korea University College of Medicine, Seoul 02841, Korea; [email protected] (E.K.C.); [email protected] (K.H.P.); [email protected] (B.M.C.) 2 Department of Obstetrics and Gynecology, Korea University College of Medicine, Seoul 02841, Korea; [email protected] (S.Y.K.); [email protected] (J.-M.H.); [email protected] (H.-J.K.) * Correspondence: [email protected]; Tel.: +82-31-412-5080 Abstract: This study aims to evaluate the perinatal outcomes of preterm premature rupture of membrane (PPROM) with latency periods at 33 + 0–36 + 6 weeks of gestation. This retrospective case-control study included women with singleton pregnancies who delivered at 33 + 0–36 + 6 weeks at Korea University Ansan Hospital in South Korea between 2006–2019. The maternal and neonatal characteristics were compared between different latency periods (expectant delivery ≥72 h vs. immediate delivery <72 h). Data were compared among 345 women (expectant, n = 39; immediate delivery, n = 306). There was no significant difference in maternal and neonatal morbidities between the groups, despite the younger gestational age in the expectant delivery group. Stratified by gestational weeks, the 34-week infants showed a statistically significant lower exposure to antenatal steroids (73.4% vs. -
OBGYN-Study-Guide-1.Pdf
OBSTETRICS PREGNANCY Physiology of Pregnancy: • CO input increases 30-50% (max 20-24 weeks) (mostly due to increase in stroke volume) • SVR anD arterial bp Decreases (likely due to increase in progesterone) o decrease in systolic blood pressure of 5 to 10 mm Hg and in diastolic blood pressure of 10 to 15 mm Hg that nadirs at week 24. • Increase tiDal volume 30-40% and total lung capacity decrease by 5% due to diaphragm • IncreaseD reD blooD cell mass • GI: nausea – due to elevations in estrogen, progesterone, hCG (resolve by 14-16 weeks) • Stomach – prolonged gastric emptying times and decreased GE sphincter tone à reflux • Kidneys increase in size anD ureters dilate during pregnancy à increaseD pyelonephritis • GFR increases by 50% in early pregnancy anD is maintaineD, RAAS increases = increase alDosterone, but no increaseD soDium bc GFR is also increaseD • RBC volume increases by 20-30%, plasma volume increases by 50% à decreased crit (dilutional anemia) • Labor can cause WBC to rise over 20 million • Pregnancy = hypercoagulable state (increase in fibrinogen anD factors VII-X); clotting and bleeding times do not change • Pregnancy = hyperestrogenic state • hCG double 48 hours during early pregnancy and reach peak at 10-12 weeks, decline to reach stead stage after week 15 • placenta produces hCG which maintains corpus luteum in early pregnancy • corpus luteum produces progesterone which maintains enDometrium • increaseD prolactin during pregnancy • elevation in T3 and T4, slight Decrease in TSH early on, but overall euthyroiD state • linea nigra, perineum, anD face skin (melasma) changes • increase carpal tunnel (median nerve compression) • increased caloric need 300cal/day during pregnancy and 500 during breastfeeding • shoulD gain 20-30 lb • increaseD caloric requirements: protein, iron, folate, calcium, other vitamins anD minerals Testing: In a patient with irregular menstrual cycles or unknown date of last menstruation, the last Date of intercourse shoulD be useD as the marker for repeating a urine pregnancy test. -
Single Stage Release Surgery for Congenital Constriction Band in a Clubfoot Patient Managed at a Teaching Hospital in Uganda: a Case Report G
Case report East African Orthopaedic Journal SINGLE STAGE RELEASE SURGERY FOR CONGENITAL CONSTRICTION BAND IN A CLUBFOOT PATIENT MANAGED AT A TEACHING HOSPITAL IN UGANDA: A CASE REPORT G. Waiswa, FCS, J. Nassaazi, MD and I. Kajja, PhD, Department of Orthopaedics, Makerere University, Kampala, Uganda Correspondence to: Dr. Judith Nassaazi, Department of Orthopaedics, Makerere University, Kampala, Uganda. Email: [email protected] ABSTRACT Congenital constriction band or amniotic band syndrome is a rare condition with a prevalence of 1:11200. It is characterized by presence of strictures around a body part, commonly around the distal part of the extremities. These bands can be treated with a single or staged approach. This study presents the case of a 3 month old infant who presented with a type III constriction band localized on the right leg and surgery was indicated. A single stage multiple Z-plasty was performed. The postoperative course was uneventful and the outcome was satisfactory at 10 months of follow-up. A single-stage constriction band release approach provided satisfactory results; both functional and aesthetic results and is feasible in our setting. Key words: Constriction bands, Single stage release, Stricture INTRODUCTION of worsening right leg deformity since birth (Figure 1). The mother reported that the child had been born Congenital constriction band or commonly referred to after a full-term pregnancy and normal delivery. This as amniotic band syndrome or Streeter dysplasia is a was the mother’s fifth child and there was no history rare condition characterized by congenital strictures of illness or drug use during pregnancy. No one else that can be partial or circumferential. -
Management of PRELABOUR RUPTURE of MEMBRANES at Term May 2014 CLINICAL PRACTICE GUIDELINE NO.13 Management of Prelabour Rupture of Membranes at Term
CLINICAL PRACTICE GUIDELINE13 Management of PRELABOUR RUPTURE OF MEMBRANES at term May 2014 CLINICAL PRACTICE GUIDELINE NO.13 Management of prelabour rupture of Membranes at term AUTHORS CONTRIBUTORS Tasha MacDonald, RM, MHSc Suzannah Bennett, MHSc Kathleen Saurette, RM Cindy Hutchinson, MSc Bobbi Soderstrom, RM CONTRIBUTORS ACKNOWLEDGEMENTS PROM CPG Working Group Megan Bobier, BA Clinical Practice Guideline Subcommittee Ontario Ministry of Health and Long-term Care Teresa Bandrowska, RM Ryerson University Midwifery Education Program Cheryllee Bourgeois, RM Elizabeth Darling, RM , MSc The Association of Ontario Midwives respectfully Corinne Hare, RM acknowledges the financial support of the Ministry of Sandy Knight, RM Health and Long-Term Care in the development of this Jenni Huntly, RM guideline. Paula Salehi, RM The views expressed in this guideline are strictly those Lynlee Spencer, RM of the Association of Ontario Midwives. No official Vicki Van Wagner, RM, PhD (c) endorsement by the Ministry of Health and Long-Term Rhea Wilson, RM Care is intended or should be inferred. Insurance and Risk Management Program ‘Remi Ejiwunmi, RM, Chair Abigail Corbin, RM Elana Johnston, RM Lisa M Weston, RM This document may be cited as: PROM CPG Working Group. Association of Ontario Midwives. Management of Prelabour Rupture of Membranes at Term. July 2010. This guideline was approved by the AOM Board of Directors: July 5, 2010 Management of PRELABOUR RUPTURE OF MEMBRANES at term Statement of purpose Methods The goal is to provide an evidence-based clinical practice A search of the Medline database and Cochrane library guideline (CPG) that is consistent with the midwifery from 1994-2009 was conducted using the key words: philosophy of care. -
Clinical Guideline Home Births
Clinical Guideline Guideline Number: CG038 Ver. 2 Home Births Disclaimer Clinical guidelines are developed and adopted to establish evidence-based clinical criteria for utilization management decisions. Oscar may delegate utilization management decisions of certain services to third-party delegates, who may develop and adopt their own clinical criteria. The clinical guidelines are applicable to all commercial plans. Services are subject to the terms, conditions, limitations of a member’s plan contracts, state laws, and federal laws. Please reference the member’s plan contracts (e.g., Certificate/Evidence of Coverage, Summary/Schedule of Benefits) or contact Oscar at 855-672-2755 to confirm coverage and benefit conditions. Summary Oscar members who chose to have a home birth may be eligible for coverage of provider services. An expectant mother has options as to where she may plan to give birth including at home, at a birthing center, or at a hospital. The American College of Obstetricians and Gynecologists (ACOG) believes that an at home birth is riskier than a birth at a birthing center or at a hospital, but ACOG respects the right of the woman to make this decision. A planned home birth is not appropriate for all pregnancies, and a screening should be done with an in-network provider to evaluate if a pregnancy is deemed low-risk and a home birth could be appropriate. Screening may include evaluating medical, obstetric, nutritional, environmental and psychosocial factors. Appropriate planning should also include arrangements for care at an in-network hospital should an emergent situation arise. Definitions “Certified Nurse-Midwife (CNM)” is a registered nurse who has completed education in a midwife program. -
Lessons Learned with the Pregnancy and Lactation Labeling Rule- Approaches to Human Data
CDER Prescription Drug Labeling Conference 2017 CDER SBIA REdI Silver Spring, MD - November 1 & 2, 2017 Two Years In: Lessons Learned with the Pregnancy and Lactation Labeling Rule- Approaches to Human Data Miriam Dinatale, DO, LCDR, USPHS Division of Pediatric and Maternal Health Center for Drug Evaluation and Research (CDER) Food and Drug Administration (FDA) Disclaimer • The views and opinions expressed in this presentation represent those of the presenter, and do not necessarily represent an official FDA position. • The labeling examples in this presentation are provided only to demonstrate current labeling development challenges and should not be considered FDA recommended templates. • Reference to any marketed products is for illustrative purposes only and does not constitute endorsement by the FDA. 2 Overview • Introduction • Review of Draft PLLR Guidance Regarding Human Data • Current Approaches to Inclusion of Human Data in Labeling • Conclusion 3 Introduction 4 The Information Gap • Human data about medical product safety in pregnancy at the time of market approval are limited or absent – Pregnant women are usually actively excluded from clinical trials. – Women who become pregnant during clinical trials are discontinued but followed. • Consequently, almost all clinically relevant human data are collected post-approval • Important goal of the PLLR conversion process is to have accurate and up-to-date labeling recommendations which reflect the post-approval experience 5 Human Data Sources for Pregnancy • Clinical Trials – Trials